Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Thomas A. Lallas"'
Autor:
Thomas A. Lallas, Richard E. Buller, John P. Geisler, Melanie A. Hatterman-Zogg, J.A. Rathe, Patricia A. Kirby
Publikováno v:
Human Mutation. 18:337-344
Recent studies have shown that the BRCA1 tumor suppressor gene plays a role in the development of both hereditary and sporadic ovarian cancer. Since several different mechanisms may give rise to tumor gene defects, a better understanding of these mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d443ee92924333669a33c32c875d5d83
https://doi.org/10.1002/humu.1195
https://doi.org/10.1002/humu.1195
Publikováno v:
Gynecologic Oncology. 76:418-422
Objective. X-Chromosome loss of heterozygosity (LOH) occurs in approximately 40% of ovarian cancers. We have previously demonstrated an association between nonrandom X-chromosome inactivation and germline BRCA1 mutation. The current study examines th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b9ee19cdb26bceabef75267dd8208d3
https://doi.org/10.1006/gyno.1999.5713
https://doi.org/10.1006/gyno.1999.5713
Publikováno v:
JNCI Journal of the National Cancer Institute. 91:339-346
Background: Most human female cells contain two X chromosomes, only one of which is active. The process of Xchromosome inactivation, which occurs early in development, is usually random, producing tissues with equal mixtures of cells having active X
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a688dd69a12cf868d2f05477c32c7926
https://doi.org/10.1093/jnci/91.4.339
https://doi.org/10.1093/jnci/91.4.339
Autor:
Philip C. Mehaffey, Bradley J. Van Voorhis, Thomas A. Lallas, Joel I. Sorosky, Donna J. Lager
Publikováno v:
Gynecologic Oncology. 72:238-242
Background. Primary malignant cervical schwannomas (malignant peripheral nerve sheath tumors) are extremely rare tumors that grossly may resemble many other more common lesions. The diagnosis, management, and follow-up of a malignant cervical schwann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec21af4fd3899db2fd5643f3da6bdfd1
https://doi.org/10.1006/gyno.1998.5234
https://doi.org/10.1006/gyno.1998.5234
Autor:
Scot A. Potts, Joel I. Sorosky, Thomas A. Lallas, Elisabeth M. Groginsky, Thomas E. Buekers, John K. Olson
Publikováno v:
Journal of Lower Genital Tract Disease. 3:67-70
j Abstract: Objective. Our aim was to report a fatal complication of hidradenitis suppurativa and a review of the literature. Materials and Methods. A case of severe hidradenitis suppurativa obscuring the diagnosis and precluding the treatment of a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8323ff8d3c5a0ea69bc45aa0e819d7de
https://doi.org/10.1046/j.1526-0976.1999.08086.x
https://doi.org/10.1046/j.1526-0976.1999.08086.x
Publikováno v:
Journal of Gynecologic Surgery. 15:55-59
Primary ovarian leiomyomas are uncommon benign tumors that are usually asymptomatic. Distinguishing them from other ovarian tumors is important in order to render the appropriate prognosis...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62e9c022d3ddf37364e21da415b32449
https://doi.org/10.1089/gyn.1999.15.55
https://doi.org/10.1089/gyn.1999.15.55
Autor:
Thomas A. Lallas, Thomas E. Buekers
Publikováno v:
Obstetrics and Gynecology Clinics of North America. 25:323-329
There is limited information concerning the effects of chemotherapy administered during pregnancy, which consists mostly of case reports and small series. The National Cancer Institute maintains a registry of neonates exposed to chemotherapy but ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91e60a69c978976452ba11dc35c8eb0
https://doi.org/10.1016/s0889-8545(05)70007-3
https://doi.org/10.1016/s0889-8545(05)70007-3
Autor:
Joel I. Sorosky, Robert Dreicer, Jacqueline K. Joyce, Barrie Anderson, Richard E. Buller, Thomas A. Lallas
Publikováno v:
American Journal of Clinical Oncology. 21:287-290
The authors performed a phase II trial of the VIG regimen (vinblastine, ifosfamide, and gallium nitrate) in patients who had advanced ovarian cancer who were refractory to cisplatin and/or carboplatin and whose disease had progressed after paclitaxel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a78dee7162746437273f05d4aa67d72
https://doi.org/10.1097/00000421-199806000-00017
https://doi.org/10.1097/00000421-199806000-00017
Publikováno v:
Molecular genetics and metabolism. 67(4)
BRCA1 mutation research in ovarian and breast cancer 17q21-linked families has yielded a large number of germline sequence variations. Somatic mutations have been uncommonly reported. We screened 81 probands with primary ovarian, peritoneal, or fallo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8efcaa40211296eabd0806c998ddac67
https://pubmed.ncbi.nlm.nih.gov/10444347
https://pubmed.ncbi.nlm.nih.gov/10444347
Autor:
Richard E. Buller, Thomas A. Lallas
Publikováno v:
Molecular genetics and metabolism. 64(3)
Single-strand confirmation polymorphism (SSCP) analysis on MDE gels has been extensively used to detect BRCA1 gene mutations. In screening a large cohort of ovarian cancer patients, our group was not completely satisfied with the standard published t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31525377566f512a5059a6d62e34a13b
https://pubmed.ncbi.nlm.nih.gov/9719625
https://pubmed.ncbi.nlm.nih.gov/9719625